FDA Approved: MIFEPRISTONE — Supplemental Application (GenBioPro, Inc.)

View source ↗

Summary

FDA approved GenBioPro, Inc.'s supplemental application for mifepristone, confirming its continued availability for established indications such as intrauterine…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cushing Syndrome
• Intrauterine Pregnancy Termination

Drugs mentioned

• Mifepristone (mifepristone)

Snippet

SUPPL AP for MIFEPRISTONE (MIFEPRISTONE)